MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE Drug Patent Profile

When do Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate patents expire, and what generic alternatives are available?

Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate is a drug marketed by Taro and is included in one NDA.

The generic ingredient in MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE is magnesium sulfate; potassium sulfate; sodium sulfate. There are one hundred and forty-six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the magnesium sulfate; potassium sulfate; sodium sulfate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate

A generic version of MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE was approved as magnesium sulfate; potassium sulfate; sodium sulfate by TARO on March 19^th, 2024.

Summary for MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Clinical Trials:	8
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE
DailyMed Link:	MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE at DailyMed

Recent Clinical Trials for MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Albert Einstein College of Medicine	Early Phase 1
Aalborg University Hospital	Phase 4
University of Minnesota	Early Phase 1

See all MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE clinical trials

Pharmacology for MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE

Drug Class	Calculi Dissolution Agent Osmotic Laxative
Mechanism of Action	Magnesium Ion Exchange Activity Osmotic Activity
Physiological Effect	Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption Inhibition Small Intestine Fluid/Electrolyte Absorption Stimulation Large Intestine Fluid/Electrolyte Secretion

Anatomical Therapeutic Chemical (ATC) Classes for MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE

A06AD	Osmotically acting laxatives
A06A	DRUGS FOR CONSTIPATION
A06	DRUGS FOR CONSTIPATION
A	Alimentary tract and metabolism

A06AD	Osmotically acting laxatives
A06A	DRUGS FOR CONSTIPATION
A06	DRUGS FOR CONSTIPATION
A	Alimentary tract and metabolism

A12CA	Sodium
A12C	OTHER MINERAL SUPPLEMENTS
A12	MINERAL SUPPLEMENTS
A	Alimentary tract and metabolism

A12CC	Magnesium
A12C	OTHER MINERAL SUPPLEMENTS
A12	MINERAL SUPPLEMENTS
A	Alimentary tract and metabolism

B05XA	Electrolyte solutions
B05X	I.V. SOLUTION ADDITIVES
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

D11AX	Other dermatologicals
D11A	OTHER DERMATOLOGICAL PREPARATIONS
D11	OTHER DERMATOLOGICAL PREPARATIONS
D	Dermatologicals

V04CC	Tests for bile duct patency
V04C	OTHER DIAGNOSTIC AGENTS
V04	DIAGNOSTIC AGENTS
V	Various

Paragraph IV (Patent) Challenges for MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
SUPREP BOWEL PREP KIT	Oral Solution	magnesium sulfate; potassium sulfate; sodium sulfate	17.5 g/3.13 g/1.6 g	022372	1	2010-11-08

US Patents and Regulatory Information for MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Taro	MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE	magnesium sulfate; potassium sulfate; sodium sulfate	SOLUTION;ORAL	206431-001	Mar 19, 2024	AA	RX	No	No